Taoyuan General Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Taoyuan City Taiwan (1979)

Organization Overview

First Clinical Trial
2000
NCT00331825
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Taoyuan General Hospital | Taoyuan General Hospital, Ministry of Health and Welfare,Taoyuan,Taiwan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 3)

Coinfection (Phase 4)

Coronavirus Infections (Phase 4)

Dyskinesia, Drug-Induced (Phase 4)

Dyskinesias (Phase 4)

Dystonia (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

HIV Infections (Phase 4)

Parkinsonian Disorders (Phase 4)

Schizophrenia (Phase 4)

Severe Acute Respiratory Syndrome (Phase 4)

Tardive Dyskinesia (Phase 4)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 17